FDA Inspection
GTX TechnologiesGTX Technologies – FDA Inspection, Jan 29, 2026
Record Details
This FDA Inspection record concerns GTX Technologies, with an inspection on January 29, 2026, issued by the Dallas District Office, covering foods & cosmetics.
View Company Profile
ID · 787743cb-aa9c-4de4-b475-272192ed24e9
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1300286
- FDA center
- Foods & Cosmetics
- Project area
- Foodborne Biological Hazards
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 111.105(g)Quality control - reserve samples
- 21 CFR 111.113Quality control operations - material review, disposition
- 21 CFR 111.503Written procedures - establish; returned dietary supplements
- 21 CFR 111.553Written procedures - establish; product complaint
- 21 CFR 111.70(b)Specifications - components
- 21 CFR 111.70(e)Specifications - finished dietary supplement
- 21 CFR 117.80(a)(2)Appropriate quality control operations
- 21 CFR 117.80(b)(1)Raw material control - Inspection
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.